Chemotherapy Advances with Dr. N. Khushalani, Dr. J. Prah and D. Thompson

Sunday, August 21, 2011

Nikhil Khushalani, MD, and Joseph Prah, MD, formerly of RPCI, discuss recent advances in cancer chemotherapeutics, including targeted therapies, FDA approval for vemurafenib and current/upcoming clinical trials. Joining the conversation is melanoma survivor Drew Thompson.